The 5 analysts offering 12-month price forecasts for Chromadex Corp have a median target of 5.50, with a high estimate of 10.00 and a low estimate of 2.10. The median estimate represents a +165.70% increase from the last price of 2.07.
The current consensus among 6 polled investment analysts is to Buy stock in Chromadex Corp. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.03
Reporting Date Mar 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.